Lipid dysregulation as a mediator of Rett syndrome disease progression
Lipid dysregulation as a mediator of Rett syndrome disease progression
批准号:
10228374
负责人:
Kari Elizabeth Neier
金额:
$6.6万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-24 至 2022-04-23
关键词:
AffectAgeAge-MonthsAnimalsAstrocytesBile AcidsBioinformaticsBody fatBrainCell NucleusCellsCharacteristicsCholesterolCholesterol HomeostasisCommunicationCritical PathwaysDataData AnalysesData SetDevelopmentDietary FatsDigestionDiseaseDisease ProgressionEnvironmentExhibitsFellowshipFemaleFunctional disorderFutureGene ExpressionGene Expression ProfileGenesGeneticGoalsHepaticHistopathologyHumanImmune systemImmunohistochemistryImpaired cognitionInflammationIntestinesIntravenousLDL Cholesterol LipoproteinsLanguageLeadershipLearningLifeLinkLipidsLiverLungMalabsorption SyndromesMeasuresMediatingMediator of activation proteinMentorsMetabolic DiseasesMetabolismMethyl-CpG-Binding Protein 2ModelingMolecularMosaicismMotorMotor SkillsMusMutateMutationNeurodevelopmental DisorderNeurologicNeurologic EffectNutritional SupportPathogenesisPathologyPatientsPhenocopyPhenotypePlayPolyunsaturated Fatty AcidsProcessProductionProtein IsoformsQuality of lifeReportingResearchResearch PersonnelResearch TrainingResolutionRett SyndromeRoleSamplingSerumSmall IntestinesSmall Nuclear RNASpeechSymptomsTechniquesTechnologyTestingTimeTissue-Specific Gene ExpressionTrainingTriglyceridesUniversitiesVenousX Inactivationabsorptioncareercausal variantclinically relevantdata integrationdocosahexaenoylascorbic acidexperiencegene therapygirlsimprovedinfancyinsightlipid metabolismlipidomicsmalemetabolic phenotypemouse modelnervous system developmentneurodevelopmentneuroinflammationnovelnovel therapeuticsskillssynaptic functionsynaptogenesistranscriptome sequencingtranscriptomicsuptake
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Lipid dysregulation is emerging as a critical component of neurodevelopmental disorders, such as Rett
syndrome (RTT). RTT is an X-linked dominant disorder caused primarily by mutations in the methyl-CpG
binding protein 2 (MECP2) gene, and predominantly affects females who are mosaic for MECP2 expression
due to X-inactivation. RTT is characterized by apparently normal development in infancy, followed by rapid
decline of motor and speech functions at 6-18 months of age. In addition to neurological effects, RTT is
increasingly recognized as a multi-system disorder, affecting the lungs, intestinal tract, immune system, and
lipid metabolism. Recent human and animal studies have strongly indicated a significant role for lipid
metabolism in RTT pathology and disease progression. Exciting new preliminary data from a mouse model of
RTT suggests a new role for lipids: lipid malabsorption in the intestinal tract. Lipids are crucial for the
developing brain. Thus, lipid malabsorption could have detrimental effects on neurodevelopment. Lipid
malabsorption can be corrected using nutritional therapies, presenting a potential opportunity for RTT
treatment. Furthermore, our preliminary data point to lipid malabsorption as a female-specific effect. Mosaic
females are the relevant clinical model, but previous studies in mice have largely focused on males completely
deficient in Mecp2. The research outlined in this fellowship proposal will therefore use an established mouse
model of RTT disease progression to evaluate whether lipid dysregulation mediates RTT disease progression
in female mosaic mice using two specific aims: 1) evaluate the contribution of lipid malabsorption to RTT
symptom progression and 2) examine the intersection of lipid and gene expression dysregulation in the brain of
RTT female mice. The findings from this research will refine the role of lipid dysregulation in RTT disease
progression and provide new avenues of treatment. The PI will train at a world-renowned research university
under Sponsor Dr. Janine LaSalle and Co-Sponsor Dr. Ameer Taha to learn new skills and techniques to carry
out this proposed research, including genetic mouse models of neurodevelopmental disorders, single-cell
transcriptomics, targeted lipidomics, and bioinformatic data analysis and integration. These research skills will
allow the PI to build on her background in studying the developmental origins of metabolic disease towards
future independent research at the intersection of neurodevelopment and lipid metabolism. In addition to new
research skills, the PI’s Sponsor will mentor her in obtaining professional development goals that will be
instrumental in the PI’s trajectory towards a career as an independent researcher: 1) maximize leadership and
management experience, hone skills at building an inclusive and diverse research environment, 3) improve
scientific communication skills, and 4) build a network of future collaborators. Together, the research and
training plan in this proposal will prepare the PI for a successful career as an independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: